Zantac Cancer Lawsuits By The Loved Ones of Those Who Have Died From Cancer
The surviving spouse, and children of Zantac cancer victims that have died, are holding the makers of the popular anti-heartburn drug accountable
Wednesday, March 24, 2021 - Thousands of individuals and the estates of loved ones who have died from cancer are suing GalaxoSmithKline and Sanofi, the makers of the best-selling Zantac (ranitidine) brand of antacid medicine. Zantac was available by prescription and over-the-counter for over two decades before being recalled by the Food and Drug Administration (FDA) on April 1, 2020. The recall contained evidence provided to the FDA by online prescription drug testing pharmacy Valisure. The scientists there found highly elevated levels of N-nitrosodimethylamine (NDMA), a well-known carcinogen. NDMA is in polluted soil, water, and air. The FDA had set 96 NGS per tablet as being the acceptable safe limit for NDMA. Valisure found some Zantac tablets to contain millions of NGS per tablet, setting off the cancer concerns. Further testing over the 12 months since the Zantac cancer scare began indicates that ranitidine is unstable and can turn into NDMA on its own when heated to a high temperature. People have written to a popular online website to describe their Zantac cancer situations. Zantac Antacid cancer lawyers represent Americans nationwide and offer a no obligation free consultation before filing a lawsuit claim.
According to people writing to AboutLawsuits.com, there are many different Zantac cancer situations, and surviving spouses and adult children are filing lawsuits on behalf of the diseased. A young women's truck-driving, fast-food eating husband died at age 62 of esophageal cancer. A young lady took Zantac/Ranitidine for more than 13 years and developed a renal mass on her kidney. A non-drinking man complained to his doctor of stomach, bowel, and chest pain. He quit taking Zantac and is feeling much better. A man with no family history of cancer died recently at age 73 of pancreatic cancer, after having taken Zantac regularly for many years. One man took Zantac for many years only to develop pancreatic, throat, and lymph node cancer. Other types of cancer being linked to taking Zantac ranitidine are uterine & cervical cancer, liver cancer, and kidney cancer, to name but a few. Zantac is also linked to developing prostate, bladder, and digestive tract cancer.
Scientific studies support the link between taking Zantac ranitidine and developing cancer. Researchers writing for Cancers, a leading medical journal at the University of Alabama, found that those using Zantac are three times as likely to develop gastrointestinal cancer. DrugWatch.com told readers, "A survey of 24,000 patients at Memorial Sloan Kettering Cancer Center found that ranitidine use was associated with an increased chance of presenting with breast, testicular, thyroid and kidney cancer." Years ago, another study found a link between ranitidine and cancer. " A 2016 study at Stanford University gave ten healthy volunteers 150 milligrams of Zantac and found that subsequent NDMA levels in their urine exceeded 47,000 nanograms. Because most of the NDMA would have metabolized before reaching the urine, the actual amount in the body could have been much higher," according to Scientific American.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.